What laboratory test is used to monitor disease progression and immune status in HIV-positive patients?

RRB Nsg. Superintendent - 29 April 2025 (Shift-3rd)

Medical & Surgical Nursing

Easy

Appeared in: RRB Nsg. Superintendent - 29 April 2025 (Shift-3rd)

Explanation

The CD4+ T cell count is the most accepted laboratory indicator for the immediate state of a patient's immunologic competence in HIV infection.
HIV directly targets and destroys CD4+ T cells, so their count is a direct measure of the damage to the immune system.
Disease progression is staged based on the CD4+ count, with a count below 200 cells/mm³ defining AIDS, the most advanced stage.
This count helps determine the risk for opportunistic infections, guiding the need for prophylactic medications.

Option B: Liver function tests (LFTs) monitor for hepatotoxicity from antiretroviral drugs or co-infections (like Hepatitis B/C), not the immune status or progression of HIV itself.
Option C: While HIV viral load correlates with the rate of disease progression, its primary clinical use is to monitor the effectiveness of antiretroviral therapy (ART). It measures the amount of virus, not the state of the immune system.
Option D: A complete blood count (CBC) is a general test that can show anemia or leukopenia, which are common in HIV, but it is not specific enough to monitor the targeted destruction of the immune system caused by the virus.

Visual 1: Chart: A graph showing the typical progression of HIV infection over time, plotting the inverse relationship between the rising HIV viral load and the declining CD4+ T cell count in an untreated individual.
Visual 2: Table: A table outlining the CDC stages of HIV infection based on CD4+ T cell counts (Stage 1: ≥500, Stage 2: 200-499, Stage 3 (AIDS): <200).

Clinical Relevance

Nursing practice connection: Knowing Laboratory monitoring of HIV infection helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
Nurses play a key role in educating patients about the meaning of their lab results, explaining that a higher CD4 count means a stronger immune system.
Monitoring CD4 counts is critical for initiating prophylaxis against opportunistic infections. For example, a nurse would anticipate an order for trimethoprim-sulfamethoxazole when a patient's CD4 count drops below 200 cells/mm³ to prevent Pneumocystis pneumonia (PCP).
What if? If a patient on stable ART has a suppressed viral load but their CD4 count is not increasing as expected, the nurse should assess for other factors like co-infections, medication adherence, or other medical conditions that could be affecting immune recovery.

How to Approach the Question

First, identify the key terms in the question: 'monitor', 'disease progression', and 'immune status' in 'HIV-positive patients'.
Recognize that the question asks for a test that reflects both the current state of the immune system and the stage of the disease.
Evaluate each option based on its primary clinical use in HIV management.
Differentiate between CD4 count and viral load. Remember: CD4 count reflects the effect of the virus on the immune system (immune status/damage), while viral load reflects the activity of the virus (replication/treatment response).
Select the option that most directly measures the health of the immune system as a marker for disease stage, which is the CD4+ T cell count.

Concept Tested & Keywords

Concept Tested: Laboratory monitoring of HIV infection.
Stem keywords: laboratory test, monitor, disease progression, immune status, HIV-positive
Lead-in keywords: What

quctrQ1C-HhSu8rZ3dHij